Why the study?
Takotsubo cardiomyopathy is an uncommon complication in patients diagnosed with COVID-19, with potential direct myocyte damage lowering the threshold for its development.
This case highlights that COVID-19 can trigger Takotsubo cardiomyopathy, which may present with symptoms mimicking acute coronary syndrome.
TSCM warrants consideration in COVID-19 with cardiac symptoms; this case leaves open direct viral myocyte injury.
COVID-19 started as an unknown viral illness and has been a challenging pandemic to overcome. The virus has been associated with multiple organ involvement, including the heart. Takotsubo cardiomyopathy (TSCM), a stress cardiomyopathy, is an uncommon complication in patients diagnosed with COVID-19. The pathogenesis is historically a result of stress onto the body that leads to a catecholamine surge. However, COVID-19 may cause direct damage to the cardiac myocytes via spike protein and angiotensin-converting enzyme 2 (ACE2) receptors which can further exacerbate the stressful insult on the patient and lower the threshold for developing TSCM. In this case report, we discuss a 94-year-old female who presented with signs and symptoms of acute coronary syndrome but, upon cardiac catheterization, was found to have basal hypercontraction with apical ballooning, consistent with TSCM.
No takes yet. Share an insight, caveat, or question.
Eftekharzadeh et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: